Figures & data
Figure 1. Double-negative T (DNT) cells in colorectal cancer (CRC) tissues.
![Figure 1. Double-negative T (DNT) cells in colorectal cancer (CRC) tissues.](/cms/asset/943f3f08-2141-4a4c-a53c-70ce909e5f80/koni_a_2373530_f0001_oc.jpg)
Figure 2. Comparison of TCRβ repertoire among CD4+, CD8+ and double-negative T (DNT) cells in colorectal cancer (CRC) tissues.
![Figure 2. Comparison of TCRβ repertoire among CD4+, CD8+ and double-negative T (DNT) cells in colorectal cancer (CRC) tissues.](/cms/asset/43ecce28-748f-447d-8a3e-6f381e9601e7/koni_a_2373530_f0002_oc.jpg)
Figure 3. Single-cell transcriptome analysis of CD8+ T and double-negative T (DNT) cells in colorectal cancer (CRC) tissues.
![Figure 3. Single-cell transcriptome analysis of CD8+ T and double-negative T (DNT) cells in colorectal cancer (CRC) tissues.](/cms/asset/8e686611-c5c2-4262-9a11-70cc8b91309c/koni_a_2373530_f0003_oc.jpg)
Figure 4. Transcriptional signature of double-negative T (DNT) cells.
![Figure 4. Transcriptional signature of double-negative T (DNT) cells.](/cms/asset/9673e73c-a100-49af-841c-43227484c161/koni_a_2373530_f0004_oc.jpg)
Figure 5. Flow cytometry of specific molecules and cytotoxic molecules in double-negative T (DNT) cells.
![Figure 5. Flow cytometry of specific molecules and cytotoxic molecules in double-negative T (DNT) cells.](/cms/asset/54335f0b-3941-430b-b6ef-f9e0e6bbe9d0/koni_a_2373530_f0005_b.gif)
Okamura_DNT_suppleTable1_20240527.pdf
Download PDF (176.1 KB)Okamura DNT_suppleFig.docx
Download MS Word (411.1 KB)Data availability statement
All data generated in this manuscript will be provided upon reasonable request to corresponding authors.